Persistence and reasons for third drug modification
Persistence and reasons for third drug modification, immunological and virological response, use of resources and costs estimation of dolutegravir-based regimens and other regimens frequently prescribed in HIV-positive patients in the cohort of the spanish AIDS research network (CoRIS)
Partners
